Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Alicja Wolk(Karolinska Institutet), D. Trichopoulos(Dana-Farber/Harvard Cancer Center), Hans‐Olov Adami(Harvard University), L. B. Signorello(Dana-Farber/Harvard Cancer Center), P. Lagiou(National and Kapodistrian University of Athens), R. Bergström(Karolinska Institutet), S.-O. Andersson(Karolinska Institutet), Christos S. Mantzoros(Beth Israel Deaconess Medical Center)
Cited by 583
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k